AVEAX
Price
$14.17
Change
-$0.81 (-5.41%)
Updated
Apr 3 closing price
Net Assets
58.32M
RGEBX
Price
$64.09
Change
-$3.82 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

AVEAX vs RGEBX

Header iconAVEAX vs RGEBX Comparison
Open Charts AVEAX vs RGEBXBanner chart's image
Ave Maria Focused
Price$14.17
Change-$0.81 (-5.41%)
VolumeN/A
Net Assets58.32M
American Funds Growth Fund of Amer R2E
Price$64.09
Change-$3.82 (-5.63%)
VolumeN/A
Net Assets279.82B
AVEAX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AVEAX vs. RGEBX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVEAX is a Buy and RGEBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 280B vs. AVEAX (58.3M). AVEAX (0.00) and RGEBX (0.00) have matching dividends . AVEAX was incepted earlier than RGEBX: AVEAX (5 years) vs RGEBX (11 years). AVEAX (1.09) and RGEBX (1.09) have similar cost to investors . RGEBX is a more actively managed with annual turnover of: 25.00 vs. AVEAX (22.00). RGEBX has a lower initial minimum investment than AVEAX: RGEBX (250) vs AVEAX (2500). AVEAX annual gain was more profitable for investors over the last year : 9.18 vs. RGEBX (-0.53).
AVEAXRGEBXAVEAX / RGEBX
Total Expense Ratio1.091.09100%
Annual Report Gross Expense Ratio1.091.09100%
Fund Existence5 years11 years-
Gain YTD-2.092-4.94142%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets58.3M280B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year9.18-0.53-1,742%
Returns for 3 years13.833.55390%
Returns for 5 yearsN/A66.95-
Returns for 10 yearsN/A53.92-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JJSF133.652.79
+2.13%
J & J Snack Foods Corp
AIMD0.540.01
+1.85%
Ainos
SGMO0.62-0.03
-4.73%
Sangamo Therapeutics
VMEO4.89-0.38
-7.21%
Vimeo
PNR81.54-7.55
-8.47%
Pentair plc